Navigation Links
Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
Date:9/18/2007

sed routinely for evaluation of melanocytic lesions. Imaging a single lesion using the VivaScope(R) required just 5 to 10 minutes according to the authors," continued Eastman, "which makes it practical for everyday use in private dermatology practices worldwide."

Study Detailed in the Journal of Investigative Dermatology

The entire paper recounting the study can be found in the Journal of Investigative Dermatology (2007), 0, 000-000, doi: 10.1038/sj.jid.5700993, "The Impact of In Vivo Reflectance Confocal Microscopy for the Diagnostic Accuracy of Melanoma and Equivocal Melanocytic Lesions," authors Giovanni Pellacani, Pascale Guitera, Caterina Longo, Michelle Avramidis, Stefania Seidenari and Scott Menzies. On the Web, visit http://dx.doi.org/10.1038/sj.jid.5700993 .

Authors Pellacani, Longo, and Seidenari are of the Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy. Guitera, Avramidis, and Menzies are of the Faculty of Medicine, Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre and Dermatology Department, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia.

This paper builds on the results of an earlier pilot study that was published in the December 2005 issue of the Journal of the American Academy of Dermatology, beginning on page 979 of that issue.

About Lucid Inc.

Lucid Inc., based in Rochester, New York, USA, is a medical device and information company dedicated to creating innovative cellular imaging technology and using the Internet to securely deliver accurate, real-time VivaScope(R) cellular resolution images to medical professionals. When coupled with its digital VivaNet(TM) system, the company's ability to image in-vivo (living) tissue will aid medical practitioners and pathologists in skin cancer screening with clarity, speed and patient comfort. For more information about Lucid Inc., visit '/>"/>

SOURCE Lucid Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Urinalysis Analyzers: Large Capabilities in Every Size Device
2. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
5. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
6. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
7. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
8. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
9. Large Study Shows that Presence of Neutralizing Antibodies Did Not Predict Clinical Response to Betaseron Treatment
10. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
11. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... Ortho-McNeil Neurologics, a,division of Ortho-McN...,that the U.S. Food and Drug Administration (FDA) ...topiramate), based on studies submitted in,respons...he use of TOPAMAX,in pediatric patients aged 1 to ...on to granting pediatric exclusivity, the FDA is c...
(Date:7/24/2008)...re/ -- There are a record 301,new medicines being ...,report released here today during a briefing that...lnesses have on patients, their families,and soci...million American,adults. The briefing, led by the ...ca (PhRMA), featured Emmy Award-winning actor Joey...
(Date:7/24/2008)...e body temperature, for home,and clinical use, WE...z-Med, Inc.,(subsidiary of American Scientific Res...ributor of the Thermofocus(R) 5-in-1 non-contact,t...a clinical study,conducted by the Second Children,...ly, which proves that the Thermofocus(R) measures ...
(Date:7/23/2008)...apy to Treat the Disease -, WAYNE, N.J. and EMERY...ayer HealthCare Pharmaceuticals and Onyx Pharmaceu...he New England Journal of Medicine published,resul...) (sorafenib),tablets decreased the absolute risk ...le hepatocellular carcinoma (HCC), or liver cancer...
Breaking Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Some Epilepsy Patients Are Good Candidates for Surgery 183 1Some Epilepsy Patients Are Good Candidates for Surgery 183 2GERD Not Limited to Grownups 181 1GERD Not Limited to Grownups 181 2GERD Not Limited to Grownups 181 3Anadys Pharmaceuticals Appoints Steve Worland Ph D as President and Chief Executive Officer 181 1Anadys Pharmaceuticals Appoints Steve Worland Ph D as President and Chief Executive Officer 181 2Anadys Pharmaceuticals Appoints Steve Worland Ph D as President and Chief Executive Officer 181 3Social parasites of the smaller kind 150 1Social parasites of the smaller kind 150 2
...lo., June 11, 2007 /PRNewswire/ -- Accera, Inc.,to...n of its Phase,IIb clinical trial of AC-1202 (Keta...s Association,s International Conference on,Preven...th the,findings of earlier clinical and preclinica...nificantly improve the memory and,cognition of sub...
....--(BUSINESS WIRE)--Jun 12, 2007 - Critical,Therap...blication,of data from a pivotal Phase III clinica...e tablets in the June 2007 issue of the,Journal of...d Drug,Administration (FDA) on May 30, 2007. Criti...artner Dey, L.P. (DEY), expects to,begin marketing...
Other Medicine Technology:Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 2Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 3Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 4Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 2Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 3Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 4Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 5
(Date:7/25/2008)... HOUSTON, July 25 /PRNewswire/ -- The Elekta Famil...cancer treatment solutions at the 2008,American As...meeting,demonstrating how the joint forces of Ele...iation therapy planning and delivery solutions tha...ter experience for,patients, as well as enhance cl...
(Date:7/25/2008)...urday can be toughest for those trying to drop pou...althDay News) -- Anyone who has avoided Monday mor...nds are not a dieter,s friend. , Now, researche...s about weekends being their undoing: Most people ...ng to lose weight. , "Weekend indulgences can w...
(Date:7/25/2008)... The Drug Information Associ...FDA) will host the Critical Path Initiative (CPI) ...r 15 -16; Bethesda, MD) and the Critical Path Tran.... , Horsham, PA (PRWEB) J... Information Association (DIA)] and the Food and D...
(Date:7/24/2008)... Hoag to lease hospital faci... Newport Beach, CA (Vocus) July 24, 2008 -- Hoa...reement with HCP, Inc. (NYSE: HCP), a Real Estate ...to lease its 175-bed hospital facility on Sand Can..., , , ,The facility is currently operated by Tene...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2
...euroscientists at Harvard Medical School and its a...o stress hormone in mice directly results in the a...issue of Behavioral Neuroscience, which is publish...iation, has this article. This would be helpful i...
...hwarz Pharma AG under which it would be acquiring ...drug that can be a treatment option for an overact...ing condition that affects up to 100 million peopl...ice chairman of Pfizer Inc and president, Pfizer H...
...ed deeply about fat cells, called adipocytes which...arch has now revealed that these Fat cells around ...heart disease. University of Iowa researchers have...cals that can cause inflammation. Fat cells, once...
...government a confirmed case of mad-cow disease in ...case was of a 6-year-old dairy cow which was ident...urveillance program for mad-cow disease. In a writ...es not affect the safety of Canadian beef. Tissues...
Other Medicine News:Health News:Link Between Stress Hormone And Depression Revealed 2Health News:Fat cells lethally connected to heart disease 2
...iagnostic collection software. Sandman Elite versi...collection software offers customizable digital fi...post recording. The scoring displays a list of sco...ing current number of events, frequency and averag...
...ur SleepWorks software and Hyppo headbox. XLTEK's ...ostic sleep-testing needs. It's compliant, accurat...ked up by 24/7 support provided by a team of knowl...t, you can expand your capabilities to include cli...
... in the Beehive product line, combines decades of ...ogy of the 21st century. Beehive Millennium is a p..., providing complete data acquisition, recording a...ilepsy monitoring applications. Beehive Millennium...
...ged unit capable of handling a wide range of stimu... research laboratories. The built-in isolation cir...s artifacts. The twin pulse circuit makes this sti...n Signal Marker For those investigators requiring ...
Medicine Products: